Name | Type | Posted | Actions |
|---|---|---|---|
Statement of Work.docx | DOCX | Jun 15, 2026 |
Agilent Dr. Oligo Pro II PMA
Contact and place of performance
Javier Aponte
Atlanta, GA 30329
USA
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Centers for Disease Control and Prevention (CDC) The Biotechnology Core Facility Branch (BCFB) within the Division of Core Laboratory and Scientific Resources (DCLSR) intends to award a firm fixed price purchase order to Agilent Technoligies Inc. 2850 Centerville RD Wilmington, Delaware 19808. Under the authori...
View moreThe instrument that is part of the service contract has many proprietary parts manufactured and sold exclusive by the proposed vendor, Agilent technologies. Only Agilent service engineers have access to all the training and parts needed to maintain the instruments at the required service levels.
The anticipated award date of this action is on or before July 01, 2026. The applicable NAICS code is 811210 Electronic and Precision Equipment Repair and Maintenance. This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the warranties and proof as being an authorized distributor of the product. Capability statements shall not exceed 2 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. Capability statements are due by 3:00 PM Eastern Standard Time (EST), June 22, 2026. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to Javier Aponte email address at: [email protected] NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.
The Centers for Disease Control and Prevention (CDC), specifically the Biotechnology Core Facility Branch within the Division of Core Laboratory and Scientific Resources, intends to award a firm-fixed-price sole source purchase order to Agilent Technologies Inc. for a service agreement. This requirement covers annual preventative maintenance for an Agilent Oligo Pro II system located in Atlanta, Georgia. The contract includes one scheduled preventative maintenance visit per year featuring full software diagnostics and critical part exchanges, as well as unlimited breakdown calls with labor, travel, and parts provided. The contractor must also provide priority response for all breakdown calls within 24 to 48 hours.
The government has identified Agilent Technologies Inc. as the only responsible source capable of satisfying this requirement under FAR 13.106-1(b)(1)(i) because the equipment contains proprietary parts manufactured and sold exclusively by the vendor. Agilent service engineers maintain exclusive access to the specialized training and components necessary to meet the required service levels. This procurement is classified under NAICS 811210 Electronic and Precision Equipment Repair and Maintenance and PSC J066 MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT, with no set-aside designated.
This special notice, identified by solicitation number 75D301-26-Q-79045, includes one attachment titled Statement of Work.docx. While this is not a request for competitive quotes, interested sources may submit a capability statement of no more than two pages demonstrating their ability to provide the required warranties and proof of status as an authorized distributor. Submissions are due via email to Javier Aponte by 3:00 PM Eastern Standard Time on June 22, 2026. The anticipated award date for this action is on or before July 01, 2026.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.